| Bladder Cancer | Dyrskjot et al. Nat Genet. (2003) 33:90-96 | Identifying distinct classes of bladder carcinoma using microarrays |  4.3 MB | Link |
| Bladder Cancer | Dozmorov et al. (2003) | Extracellular matrix-modulation of malignant phenotype in bladder | 0.1 MB | Link |
| Brain Cancer | Pomeroy et al. (2002) Nature 415:436-42 | Prediction of central nervous system embryonal tumour outcome based on gene expression | 6.6 MB | Link |
| Brain Cancer | Liang et al. (2005) PNAS 102:5814-9 | Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme | 18.1 MB | Link |
| Brain Cancer | Dong et al. (2005) J Neuropathol Exp Neurol. 64:948-55 | Histology-based expression profiling yields novel prognostic markers in human glioblastoma | 8.4 MB | Link |
| Brain Cancer | Bredel et al. (2005) Cancer Cancer Res. 65:8679-89; Bredel et al. (2006) J Clin Oncol. 24:274-87 | Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas | 23.2 MB | Link |
| Brain Cancer | Ma et al. (2005) Cancer Res. 65:5523-34 | Autocrine platelet-derived growth factor-dependent gene expression in glioblastoma cells is mediated largely by activation of the transcription factor sterol regulatory element binding protein and is associated with altered genotype and patient survival in human brain tumors | 5.2 MB | Link |
| Brain Cancer | Bredel et al. (2006)J Clin Oncol. 24:274-87 | Tumor necrosis factor-alpha-induced protein3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas | 8.5 MB | Link |
| Brain Cancer | Fine et al. (2006) | Glioma-derived stem cell factor effect on angiogenesis in the brain | 121.7 MB | Link |
| Breast Cancer | Perou CM et al.(1999) PNAS 96:9212-7 | Distinctive gene expression patterns in human mammary epithelial cells and breast cancers | 0.8 MB | Link |
| Breast Cancer | Perou CM et al.(2000) Nature 406:747-52 | Molecular portraits of human breast tumours | 14.9 MB | Link |
| Breast Cancer | Sorlie et al.(2001) PNAS 98:10869-74 | Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications | 18.3 MB | Link |
| Breast Cancer | van't Veer et al.(2002) Nature 415:530-6 | Gene expression profiling predicts clinical outcome of breast cancer | 21.4 MB | Link |
| Breast Cancer | Sotiriou et al.(2003) PNAS 100:10393-8 | Breast cancer classification and prognosis based on gene expression profiles from a population-based study | 9.9 MB | Link |
| Breast Cancer | Sorlie et al.(2003) PNAS 100:8418-2398 | Repeated observation of breast tumor subtypes in independent gene expression data sets | 48.7 MB | Link |
| Breast Cancer | Chang et al. (2003) Lancet 362:362-9 | Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer | 7.1 MB | Link |
| Breast Cancer | Ma et al. (2004) Cancer Cell 5:607-16 | A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen | 14.3 MB 14.2 MB | Link |
| Breast Cancer | Troester et al. (2004) Cancer Res. 64:4218-26 | Cell-type-specific responses to chemotherapeutics in breast cancer | 13.8 MB | Link |
| Breast Cancer | Acevedo et al. (2004) Mol Cell. 13:725-38 | Selective recognition of distinct classes of coactivators by a ligand-inducible activation domain | 7.2 MB | Link |
| Breast Cancer | Frasor et al. (2004) Cancer Res. 64:1522-33 | Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells | 5.1 MB | Link |
| Breast Cancer | Yang et al.(2005) Clin Cancer Res 11:6226-32 | Gene expression patterns and profile changes pre- and post-erlotinib treatment in patients with metastatic breast cancer | 10.0 MB | Link |
| Breast Cancer | Moqqi et al. (2005) J Mol Endocrinol. 34:535-51 | Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes | 7.6 MB | Link |
| Breast Cancer | Farmer et al. (2005) Oncogene 24:4660-71 | Identification of molecular apocrine breast tumours by microarray analysis | 15.2 MB | Link |
| Cancer Cell Lines | Ross et al. (2000) Nat Genet. 24:227-35 | Systematic variation in gene expression patterns in human cancer cell lines | 4.7 MB | Link |
| Colon Cancer | Alon et al. (1999) PNAS 96:6745-50 | Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays | 1.4 MB | Link |
| Colon Cancer | Fleet et al. (2003) Physiol Genomics. 13:57-68 | Gene expression profiling of Caco-2 BBe cells suggests a role for specific signaling pathways during intestinal differentiation | 4.2 MB | Link |
| Colon Cancer | Anderle et al. (2004) | Intestinal epithelial cell immune response | 10.0 MB | Link |
| Colon Cancer | Bandres et al. (2005) | Gene signature for relapse prediction in DukesB colon cancer | 4.9 MB | Link |
| Colon Cancer | Dommels et al. (2005) | Folic acid deficiency effect on colon cancer cells | 2.8 MB | Link |
| Colon Cancer | West et al. (2005) Chem Res Toxicol. 18:1642-53 | Alterations in gene expression induced by the lipid peroxidation product, 4-hydroxy-2-nonenal | 24.8 MB | Link |
| Colon Cancer | Yang et al. (2005) | Transgenic Kruppel-like factor 4 induction: time course | 7.8 MB | Link |
| Colon Cancer | Koinuma et al. (2006) Oncogene 25:139-46 | pigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability | 8.2 MB 7.7 MB | Link |
| Cervical Cancer | Wong et al. (2003) Clin Cancer Res. 9:5486-92 | Molecular Classification and Prediction of Radiotherapy Response by DNA Microarray | 4.8 MB | Link |
| Embryonal Cancer | Skotheim et al. (2005) Cancer Res. 65:5588-98 | Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development | 3.5 MB | Link |
| Endometrial Cancer | Wu et al. (2005) Nature 438:981-7 | Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis | 4.7 MB | Link |
| Esophageal Cancer | Kimchi et al. (2005) Cancer Res. 65:3146-54 | Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation | 10.6 MB | Link |
| Ewing Family Tumor | Staege et al. (2004) Cancer Res. 64:8213-21 | DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets | 7.1 MB | Link |
| Gastric Cancer | Hippo et al.(2002) Cancer Res. 62:233-40 | Global gene expression analysis of gastric cancer by oligonucleotide microarrays | 3.7 MB | Link |
| Gastric Cancer | Chen et al.(2003) Mol Biol Cell 14:3208-15 | Variation in gene expression patterns in human gastric cancers | 112.6 MB | Link |
| Gastric Cancer | Subramanian et al.(2004) Oncogene 23:7780-90 | Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles | 22.3 MB | Link |
| Head and Neck Cancer | Chung et al. (2004) Cancer Cell 5:489-500 | Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression | 8.6 MB | Link |
| Head and Neck Cancer | Cromer et al. (2004) Oncogene 23:2484-98 | Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis | 7.3 MB | Link |
| Head and Neck Cancer | O'Donnell et al. (2005) Oncogene 24:1244-51 | Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity | 10.4 MB | Link |
| Leukemia | Cheok et al. (2003) Nat Genet. 34:85-90 | Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells | 22.0 MB | Link |
| Leukemia | Yaqi et al. (2003) Blood 102:1849-56 | Identification of a gene expression signature associated with pediatric AML prognosis | 9.2 MB | Link |
| Leukemia | Addya et al. (2004) Physiol Genomics. 19:117-30 | Erythroid-induced commitment of K562 cells results in clusters of differentially expressed genes enriched for specific transcription regulatory elements | 7.2 MB | Link |
| Leukemia | Raetz et al. (2006) Pediatr Blood Cancer 47:130-40 | Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma | 10.8 MB | Link |
| Leukemia | Steqmaier et al. (2004) Nat Genet. 36:257-63 | Gene expressionbased high-throughput screening(GE-HTS) and application to leukemia differentiation | 3.7 MB | Link |
| Leukemia | Steqmaier et al. (2004) Nat Genet. 36:257-63 | Gene expressionbased high-throughput screening(GE-HTS) and application to leukemia differentiation | 22.5 MB 3.7 MB | Link |
| Leukemia | Scandura et al. (2004) Proc Natl Acad Sci U S A. 101:15231-6 | Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation | 7.1 MB | Link |
| Leukemia | Haslinger et al. (2004) J Clin Oncol. 22:3937-49 | Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status | 22.9 MB | Link |
| Leukemia | Neumann et al. (2005) Leukemia 19:458-60 | Gene expression profiling of Philadelphia chromosome (Ph)-negative CD34+ hematopoietic stem and progenitor cells of patients with Ph-positive CML in major molecular remission during therapy with imatinib | 3.2 MB | Link |
| Leukemia | Gutierrez et al. (2005) Leukemia19:402-9 | Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia | 13.4 MB | Link |
| Leukemia | Crossman et al. (2005) Haematologica 90:459-64 | In chronic myeloid leukemia white cells from cytogenetic responders and non-responders to imatinib have very similar gene expression signatures | 6.4 MB | Link |
| Leukemia | De Pitta et al. (2005) Haematologica 90:890-8 | A leukemia-enriched cDNA microarray platform identifies new transcripts with relevance to the biology of pediatric acute lymphoblastic leukemia | 2.9 MB | Link |
| Leukemia | Dik et al. (2005) Leukemia 19:1948-57 | CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes | 11.7 MB | Link |
| Leukemia | Falt et al. (2005) Exp Hematol. 33:883-93 | Identification of progression markers in B-CLL by gene expression profiling | 5.3 MB | Link |
| Liver Cancer | Ye et al. (2003) Nat Med. 9:416-423 | Predicting hepatitis B viruspositive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning | 4.5 MB | Link |
| Lung Cancer | Bhattacharjee et al. (2001) PNAS 98:13790-5 | Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses | 24.8 MB | Link |
| Lung Cancer | Beer et al. (2002) Nat Med 8:816-24 | Gene-expression profiles predict survival of patients with lung adenocarcinoma | 8.2 MB | Link |
| Lung Cancer | Garber et al. (2001) PNAS 98:13784-9 | Diversity of gene expression in adenocarcinoma of the lung | 32.1 MB | Link |
| Lung Cancer | Gordon et al. (2002) Cancer Research 62:4963-7 | Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma | 23.1 MB | Link |
| Lung Cancer | Michael et al. (2004) | Two prognostically significant subtypes of high-grade lung neuroendocrine tumors independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles | 26.4 MB | Link |
| Lung Cancer | Magda et al. (2005) | Lung cancer cell line response to motexafin gadolinium | 8.0 MB | Link |
| Lung Cancer | Washi et al. (2005) | Squamous Lung Cancer, Paired Samples | 6.7 MB | Link |
| Lung Cancer | Gemma et al. (2006) | Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database | 11.8 MB | Link |
| Lymphoma | Rosenwald et al. (2002) NEJM 346:1937-47 | The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma | 33.3 MB | Link |
| Lymphoma | Shipp et al. (2002) Nat Med 8:68-74 | Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning | 8.3 MB | Link |
| Lymphoma | Rosenwald et al. (2003) Cancer Cell 3:185-97 | The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma | 12.2 MB | Link |
| Lymphoma | Dave et al. (2004) NEJM 351:2159-69 | Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells | 103.5 MB | Link |
| Lymphoma | Fan et al. (2005) | Gene Expression Profile of Primary Effusion Lymphoma | 9.4 MB | Link |
| Medulloblastoma | MacDonald et al. (2001) 29:143-52 | Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease | 1.0 MB | Link |
| Melanoma | Bittner et al. (2000) Nature 406:536-40 | Molecular classification of cutaneous malignant melanoma by gene expression profiling | 2.3 MB | Link |
| Melanoma | Smith et al. (2005) Cancer Biol Ther. 4:1018-29 | Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas | 19.1 MB | Link |
| Melanoma | Talantov et al. (2005) Clin Cancer Res. 11:7234-42 | Novel genes associated with malignant melanoma but not benign melanocytic lesions | 22.8 MB | Link |
| Melanoma | Winnepenninckx et al. (2006) J Natl Cancer Inst. 98(7):472-82. | Gene expression profiling of primary cutaneous melanoma and clinical outcome | 42.9 MB
10.1 MB | Link |
| Mesothelioma | Gordon et al. (2005) | Malignant pleural mesothelioma | 15.7 MB | Link |
| Myeloma | Tian et al. (2003) N Engl J Med. 349:2483-94 | The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma | 30.6 MB | Link |
| Myeloma | Mattioli et al. (2005) Oncogene 24:2461-2473 | Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma | 15.3 MB | Link |
| Osteosarcoma | Stossi et al. (2004) Endocrinology 145:3473-86 | Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptors | 5.9 MB | Link |
| Osteosarcoma | Monroe et al. (2005) Mol Endocrinol. 19:1555-68 | Estrogen receptor alpha and beta heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells | 7.2 MB | Link |
| Ovarian Cancer | Peters et al. (2004) | Carboplatin Sensitivity in Ovarian Carcinoma | 6.1 MB | Link |
| Pancreatic Cancer | Mano et al. (2005) | Expression profile of pancreatic ductal cells | 26.8 MB 13.8 MB | Link |
| Prostate Cancer | Dhanasekaran et al.(2001) Nature 412:822-6 | Delineation of prognostic biomarkers in prostate cancer | 5.3 MB | Link |
| Prostate Cancer | Singh et al. (2002) Cancer Cell 1:203-9 | Gene expression correlates of clinical prostate cancer behavior | 10.0 MB | Link |
| Prostate Cancer | Buchsbaum et al. (2003) | Prostate adenocarcinoma and ionizing radiation | 3.8 MB | Link |
| Prostate Cancer | Lapointe et al. (2004) PNAS 101:811-6 | Gene expression profiling identifies clinically rele vant subtypes of prostate cancer | 86.9 MB | Link |
| Prostate Cancer | Chen et al. (2004) Nat Med. 10:33-9 | Molecular determinants of resistance to antiandrogen therapy | 4.6 MB 9.5 MB | Link |
| Prostate Cancer | Best et al. (2005) Clin Cancer Res. 11:6823-34 | Molecular alterations in primary prostate cancer after androgen ablation therapy | 9.7 MB | Link |
| Prostate Cancer | Varambally et al. (2005) Cancer Cell. 8:393-406 | Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression | 24.5 MB | Link |
| Prostate Cancer | Nanni et al. (2006) Mol Cancer Res. 4:79-92 | Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer | 11.3 MB | Link |
| Pediatric sarcoma | Baer et al. (2005) | Pediatric sarcoma: rhabdomyosarcoma & Ewing's sarcoma | 5.8 MB | Link |
| Renal Cancer | Vasselli et al. (2003) PNAS 100:6958-63 | Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor | 9.7 MB | Link |
| Renal Cancer | Boer et al. (2001) Genome Research 11:1861-1870 | Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array | 61.7 MB 61.7 MB | Link |
| Renal Cancer | Lenburg et al. (2003) BMC Cancer3:31 | Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data | 8.9 MB 8.8 MB | Link |
| Renal Cancer | Boni et al. (2005) Clin Pharm Ther. 77:76-89 | Population pharmacokinetics of CCI-779: Correlations to safety and pharmacogenomic responses in patients with advanced renal cancer | 17.9 MB | Link |
| Renal Cancer | Tsui et al. (2005) | Clear cell sarcoma of the kidney | 14.9 MB | Link |
| Renal Cancer | Yang et al. (2005) Cancer Res. 65:5628-37 | A molecular classification of papillary renal cell carcinoma | 27.9 MB | Link |
| Soft Tissue Sarcoma | West et al. (2005) PLoS Biol 3:e187 | Determination of stromal signatures in breast carcinoma | 47.2 MB | Link |
| Soft Tissue Sarcoma | Yoon et al. (2005) | Gene expression of human soft tissue sarcoma | 18.3 MB | Link |
| Thyroid Cancer | Reyes et al. (2005) | Papillary thyroid cancer versus paired normal thyroid tissue | 20.7 MB | Link |
| Uterine Leiomyoma | Hoffman et al. (2003) | Uterine Fibroid and Normal Myometrial Expression Profiles | 6.7 MB | Link |
| Uterine Leiomyoma | Quade et al. (2003) | Comparison of Gene Expression in Uterine Smooth Muscle Tumors | 3.1 MB | Link |
